Psychosexual Disorders and Conditions Related to Sexual Health
Psychosexual disorders is an older umbrella term. ICD-11 places sexual dysfunctions, sexual pain disorders and gender incongruence under conditions related to sexual health, while paraphilic disorders remain mental/behavioural diagnoses only when defined clinical requirements are met. Sexual orientation—including homosexuality—is not a disorder. Care must be consensual, confidential, non-judgmental, culturally sensitive and rights-based.
Classification
| Group | Examples | Essential clinical principle |
|---|
| Sexual dysfunction | Low desire/arousal, erectile disorder, orgasmic/ejaculatory dysfunction | Persistent/recurrent difficulty with distress; assess biological, psychological, relationship and medicine factors. |
| Sexual pain | Pain with intercourse/penetration difficulties | Exclude infection, injury, pelvic disease, menopause-related changes and trauma; never force examination. |
| Paraphilic disorder | Persistent atypical arousal pattern with acted-on non-consenting behaviour or marked distress/impairment under ICD criteria | Atypical interest alone is not automatically a disorder; safeguarding and consent are central. |
| Gender incongruence | Persistent incongruence between experienced gender and assigned sex | Not classified as a mental disorder in ICD-11; provide respectful health care and address distress, stigma or coexisting illness. |
Normal sexual response and determinants
Sexual wellbeing involves desire, arousal, orgasm, comfort, consent, communication and satisfaction. It is influenced by endocrine, neurological, vascular and genital function; age and reproductive stage; chronic disease; medicines; body image; past trauma; relationship safety; culture and privacy. Variability is normal unless the person experiences distress, impairment or risk.
Causes and risk factors
- Physical: diabetes, cardiovascular/neurological disease, pelvic conditions, childbirth injury, menopause, pain, infection and disability.
- Medicines/substances: antidepressants, antipsychotics, antihypertensives, opioids, alcohol and other substances.
- Psychological: depression, anxiety, performance fear, trauma, shame, psychosis and body-image difficulty.
- Relational/social: conflict, poor communication, coercion, infertility stress, stigma, lack of privacy and gender-based violence.
Assessment
- Ensure privacy, explain confidentiality and its safeguarding limits, seek permission before sexual questions and use the patient’s terms.
- Clarify the concern, onset, situations, distress, sexual response phases, pain, reproductive/menstrual history, illnesses, medicines, substances and relationship context.
- Ask directly but sensitively about consent, coercion, assault, child/at-risk-person involvement, STI/HIV risk, pregnancy and self-harm.
- Perform mental-state and targeted physical examination only when indicated, consented and within competence; offer a chaperone. Trauma-informed care allows the patient to pause or stop.
- Investigations are cause-directed: glucose, endocrine tests, pregnancy/STI/HIV testing with consent, medication review and relevant pelvic/urological evaluation.
Management
- Education: correct myths, explain normal variation and the sexual response cycle, promote consent and safer sex.
- Treat underlying causes: optimize diabetes/cardiovascular disease, pain, infection, depression and substance use; review offending medicines without abrupt discontinuation.
- Psychological/relationship care: CBT-based work, anxiety reduction, gradual sensate-focus exercises, trauma therapy when stable, and couples therapy only when safe and mutually chosen.
- Sexual pain: multidisciplinary gynaecological/urological assessment, lubrication/moisturizer where appropriate, pelvic-floor therapy and graded treatment; penetration is never a treatment obligation.
- Erectile dysfunction: cardiovascular assessment, lifestyle change and prescribed PDE-5 inhibitor when suitable. Nitrates are a major contraindication because profound hypotension may occur.
- Paraphilic disorder: specialist risk assessment, psychotherapy and selected medicines; immediately protect children/non-consenting persons, follow Ugandan safeguarding/reporting law and avoid vigilante or humiliating responses.
Medicine safety
| Medicine | Use | Contraindications/adverse effects/interactions |
|---|
| Sildenafil/PDE-5 inhibitors | Erectile dysfunction after assessment | Never combine with nitrates; caution severe cardiovascular disease and alpha-blockers. Headache, flushing, dyspepsia, visual symptoms; prolonged painful erection is an emergency. |
| SSRIs | Some compulsive sexual/paraphilic symptoms and premature ejaculation under specialist care | May reduce desire/orgasm; serotonin interactions, hyponatraemia and early activation/suicide monitoring. |
| Hormonal/antiandrogen treatment | Rare high-risk paraphilic disorder under specialist/legal framework | Metabolic, bone, cardiovascular, sexual and mood effects; requires consent, laboratory and physical monitoring. |
Nursing care
| No. | Intervention | Rationale/evaluation |
|---|
| 1 | Provide privacy, neutral language and permission-based history. | Reduces shame and improves disclosure; evaluate trust and complete assessment. |
| 2 | Assess coercion, violence, STI/pregnancy and safeguarding risk. | Identifies urgent protection and treatment needs. |
| 3 | Review illness/medicines and coordinate appropriate referral. | Many dysfunctions are reversible or signal systemic disease. |
| 4 | Teach consent, safer sex, medicine use and follow-up red flags. | Promotes autonomy, prevention and adherence. |
Revision questions
- Explain why homosexuality is not a disorder.
- Describe a biopsychosocial sexual history.
- State contraindications and nursing teaching for sildenafil.
References
- WHO. ICD-11 Clinical Descriptions and Diagnostic Requirements, 2024.
- WHO. ICD-11 Chapter 17: Conditions Related to Sexual Health.
